Provided by Tiger Fintech (Singapore) Pte. Ltd.

Helmerich & Payne

23.14
+0.24001.05%
Volume:693.04K
Turnover:16.00M
Market Cap:2.30B
PE:-69.52
High:23.26
Open:23.10
Low:22.80
Close:22.90
52wk High:37.46
52wk Low:14.65
Shares:99.44M
Float Shares:95.46M
Volume Ratio:0.40
T/O Rate:0.73%
Dividend:1.00
Dividend Rate:4.32%
EPS(TTM):-0.3329
EPS(LYR):3.43
ROE:-1.00%
ROA:3.73%
PB:0.83
PE(LYR):6.74

Loading ...

Helmerich and Payne Inc : Susquehanna Raises Target Price to $26 From $23

THOMSON REUTERS
·
Oct 02

HP Accelerates the Future of Work

GlobeNewswire
·
Oct 02

Nokia to license technology from HP Enterprise

TIPRANKS
·
Oct 02

HP Enterprise price target raised to $27 from $25 at Goldman Sachs

TIPRANKS
·
Oct 02

HP Inc. says Ketan Patel to succeed Alex Cho as president of personal systems

TIPRANKS
·
Oct 01

HP Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Oct 01

Helmerich & Payne Announces New President Appointment

TIPRANKS
·
Sep 30

Helmerich & Payne Announces Trey Adams as President, Promotes Mike Lennox and John Bell to Executive Vice Presidents

Reuters
·
Sep 29

Synopsys, NuScale, HP, Prospect, General Mills: Stock Moves Unveiled!

TIPRANKS
·
Sep 27

HP Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Sep 26

HP Inc. Stock Slides 3.6%, Underperforms Peers

Dow Jones
·
Sep 25

A Fresh Look at HP (HPQ) Valuation After Surpassing Q3 2025 Earnings Expectations

Simply Wall St.
·
Sep 24

HP Inc Server HP DL388 Gen10 2U Rack-mount Available at Special Promotional Price

Deep News
·
Sep 23

HP DL388 Gen10 Server with Silver 4210/32GB/960GB Available in Chengdu for 12,999 Yuan

Deep News
·
Sep 23

Helmerich & Payne Shares Rise After Barclays Upgrade

MT Newswires Live
·
Sep 23

Helmerich & Payne Raised to Overweight From Equal-Weight by Barclays

Dow Jones
·
Sep 22

MBX Biosciences Announces Once-Weekly Canvuparatide Achieved Primary Endpoint in Phase 2 Trial with 63% Responder Rate at 12 Weeks; 79% Responder Rate at 6 Months in Open-Label Extension

GlobeNewswire
·
Sep 22

Barclays Upgrades Helmerich & Payne to Overweight From Equalweight, Adjusts PT to $25 From $17

MT Newswires Live
·
Sep 22

Helmerich & Payne upgraded to Overweight from Equal Weight at Barclays

TIPRANKS
·
Sep 22

MBX Biosciences to Provide Topline Results from its Phase 2 Trial of Potential Once-Weekly Canvuparatide for Hypoparathyroidism (HP) on Monday, September 22

GlobeNewswire
·
Sep 20